FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Date of Report (Date of earliest event reported): July 15, 2004 MEDTOX SCIENTIFIC, INC. Delaware |
1-11394 | 95-3863205 |
(Commission File Number) | (IRS Employer Identification No.) |
402 West County Road D | |
St. Paul, Minnesota | 55112 |
(Address of principal executive offices) | (Zip Code) |
(651) 636-7466 1 |
Item 12. Results of Operations and Financial Condition. On July 15, 2004, the Company held its quarterly conference call and announced results for the second quarter ended June 30, 2004, as described in the conference call script attached as Exhibit 99.1. 2 |
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. |
MEDTOX Scientific, Inc. | ||
Date: July 15, 2004 | By: /s/ Richard J. Braun | |
Name: Richard J. Braun | ||
Title: Chief Executive Officer |
3 |